Log In
Print this Print this

Intranasal influenza vaccine, NasoVAX (Recombinant influenza vaccine)

  Manage Alerts
Collapse Summary General Information
Company Altimmune Inc.
DescriptionHemagglutinin (HA) gene delivery to nasal mucosa using a non-replicating adenovirus vector
Molecular Target
Mechanism of ActionGene therapy; Vaccine
Therapeutic ModalityPreventive vaccine
Latest Stage of DevelopmentPhase I
Standard IndicationInfluenza virus
Indication DetailsPrevent influenza virus infection; Vaccinate against influenza virus
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today